Supplementary Files
Keywords
Skin cancer
Non-melanoma skin cancer
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To provide, through a narrative review, a broad approach to the surgical treatment of Non-Melanoma Skin Cancer (NMSC). Bibliographic review: NMSC, which corresponds to Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), is currently the most common cancer in the world in all age groups and in both sexes. This type of neoplasm has a lower mortality rate if treated correctly. The main known risk factor associated with the development of the disease is chronic and excessive exposure to the sun. Once diagnosed by the dermatologist, NMSC has a series of treatments available that vary according to the characteristics of each lesion. Surgery for both BCC and SCC is considered the treatment of choice by professionals in the field, with the highest cure rates and lowest recurrence rates. Final considerations: Early detection of NMSC cases and the institution of appropriate treatment in a timely manner is essential to avoid unfavorable outcomes. The surgical approach is currently considered the best therapeutic strategy for this type of neoplasm.
References
AN S, et al. Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis. Cancers (Basel), 2021; 13(23): 5940.
CAINI S, et al. Vitamin D and the Risk of Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis on Behalf of the Italian Melanoma Intergroup. Cancers (Basel), 2021; 13(19): 4815.
CAPARROTTI F, et al. Localized Non-melanoma Skin Cancer: Risk Factors of Post-surgical Relapse and Role of Postoperative Radiotherapy. Current Treatment Options in Oncology, 2020; 21(12): 97.
DIDONA D, et al. Non Melanoma Skin Cancer Pathogenesis Overview. Biomedicines, 2018; 6(1): 6.
GRUPO BRASILEIRO DE MELANOMA. CEC de pele. Livreto GBM, 2019; 2(1): 1-20
LIU R, et al. Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis. Cancer Cell International, 2021; 21(1): 614.
MORTON CA. A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin câncer. G Italian Journal of Dermatology and Venereology, 2018; 153(6): 783-792.
NIKOLOUZAKIS TK, et al. Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer.Journal of Clinical Medicine, 2020; 9(9): 2868.
RULLO EV, et al. Non-Melanoma Skin Cancer in People Living With HIV: From Epidemiology to Clinical Management. Frontiers in Oncology, 2021; 11: 689789.
SHALHOUT SZ. Immunotherapy for Non-melanoma Skin Cancer. Current Oncology Reports, 2021; 23(11): 125.
SOCIEDADE BRASILEIRA DE PEDIATRIA. Carcinoma basocelular. Associação Médica Brasileira e Conselho Federal de Medicina, 2002; 1(2): 1-16.
STONESIFER CJ, et al. Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence. Frontiers in Oncology, 2021; 11: 734354.
TAMAS T, et al. Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution? Genes (Basel), 2021; 12(12): 1929.
TANESE K, et al. Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer. Frontiers of Medicine(Lausanne), 2019; 6: 160.
ZELIN E, et al. Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma. Current Treatment Options in Oncology, 2021; 22(4): 35.